Portfolio Update

3 October 2007

                  FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC                  

                                (the "Company")                                

                      QUARTERLY STATEMENT OF INVESTMENTS                       

In compliance with the Listing Rules - Chapter 21 Investment Entities (I)(ii),
the Company discloses the following:

  * Investments valuing greater than 5% of the Company's gross assets comprise
    the following:
   
Company Name                                        Value of       % of Total  
                                                 Investment at      Portfolio  
                                                                     Assets    
                                               30 September 2007               
                                                                               
GEN-PROBE INC USD0.0001                            15,916,162         5.63     
                                                                               
GENENTECH INC COM STK USD0.02 NPV                  15,348,573         5.43     
                                                                               
AMGEN COM USD0.0001                                15,196,493         5.38     

  * The ten largest investments held by the Company comprise the following:
   
Company Name                                  Value of Investment   % of Total 
                                                       at           Portfolio  
                                                                      Assets   
                                               30 September 2007               
                                                                               
GEN-PROBE INC USD0.0001                            15,916.162          5.63    
                                                                               
GENENTECH INC COM STK USD0.02 NPV                  15,348,573          5.43    
                                                                               
AMGEN COM USD0.0001                                15,196,493          5.38    
                                                                               
NOVARTIS CHF0.50 REGD                              13,497,899          4.78    
                                                                               
TAKEDA PHARMACEUTICAL CO NPV                       13,431,299          4.75    
                                                                               
SCHERING-PLOUGH CORPORATION COM USD0.50            13,241,642          4.69    
                                                                               
ROCHE HLDGS CHF1 BR                                13,180,042          4.66    
                                                                               
ABBOTT LABS COM NPV USD                            11,678,877          4.13    
                                                                               
GENZYME CORP GENERAL DIVISION COM USD0.01          10,705,485          3.79    
                                                                               
VERTEX PHARMACEUTICALS COM USD0.01                 9,412,216           3.33    

                                   - ENDS -                                    

For further information please contact:

Mark Pope, Company Secretary

Frostrow Capital LLP

Telephone: [phone]